Pediatric Rehabilitation
Developmental delays, cerebral palsy and pediatric mobility.
Pediatric rehabilitation has been reshaped by disease-modifying therapies in neuromuscular disease and refined surgical and pharmacologic options for cerebral palsy. The track will cover the rehabilitative implications of onasemnogene abeparvovec (Zolgensma), risdiplam, and nusinersen in SMA, exon-skipping and gene therapy in DMD (delandistrogene moxeparvovec), and longitudinal motor outcomes. CP content includes selective dorsal rhizotomy patient selection, intrathecal baclofen pump management, and single-event multilevel surgery rehabilitation. Sessions will also address constraint-induced movement therapy in hemiplegic CP, pediatric power mobility provision, and transition-of-care models from pediatric to adult rehabilitation services.
- Rehab implications of SMA therapies: onasemnogene, risdiplam, nusinersen
- DMD gene therapy and exon-skipping rehabilitation outcomes
- Selective dorsal rhizotomy and intrathecal baclofen in CP
- Single-event multilevel surgery (SEMLS) post-op rehabilitation
- Constraint-induced movement therapy in hemiplegic CP
- Pediatric power mobility and seating provision
- Transition of care from pediatric to adult rehabilitation